STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution



STRATEC Biomedical AG 

25.04.2013 15:57

Dissemination of a Voting Rights Announcement, transmitted by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.




Correction of the voting rights notification dated April 24, 2013


1. Ameriprise Financial, Inc.

On April 24, 2013 Ameriprise Financial, Inc., Minneapolis, Minnesota, USA, has sent us the following correction of their voting rights notification dated April 23, 2013:

Ameriprise Financial, Inc., Minneapolis, Minnesota, USA, has notified us pursuant to sec. 21 para. 1 WpHG, that on 18 April 2013 the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001 went above the threshold of 5% and that the percentage of voting rights on that day amounted to 5.39% (633,000 voting rights).
Ameriprise Financial, Inc. has notified us that these voting rights of 5.39% (633,000 voting rights) are attributable to Ameriprise Financial, Inc. pursuant to sec. 22 para. 1 sent. 1 no. 6 in connection with sent. 2 WpHG.

The voting rights were attributed to Ameriprise Financial, Inc. inter alia from Threadneedle Investment Funds ICVC, being a shareholder holding 3% or more of the voting rights in STRATEC Biomedical AG.


2. Threadneedle Asset Management Holdings SARL

On April 24, 2013 Threadneedle Asset Management Holdings SARL, Luxembourg, Luxembourg, has sent us the following correction of their voting rights notification dated April 23, 2013:

Threadneedle Asset Management Holdings SARL, Luxembourg, Luxembourg, has notified us pursuant to sec. 21 para. 1 WpHG, that on 18 April 2013 the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001 went above the threshold of 5% and that the percentage of voting rights on that day amounted to 5.35% (628,462 voting rights).
Threadneedle Asset Management Holdings SARL has notified us that these voting rights of 5.35% (628,462 voting rights) are attributable to Threadneedle Asset Management Holdings SARL pursuant to sec. 22 para. 1 sent. 1 no. 6 in connection with sent. 2 WpHG.

The voting rights were attributed to Threadneedle Asset Management Holdings SARL inter alia from Threadneedle Investment Funds ICVC, being a shareholder holding 3% or more of the voting rights in STRATEC Biomedical AG.



25.04.2013 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

 
Language:     English
Company:      STRATEC Biomedical AG
              Gewerbestr. 37
              75217 Birkenfeld
              Germany
Internet:     www.stratec.com
 
End of Announcement DGAP News-Service  




back